AFP and hepatocellular carcinoma: Compared with AFP-negative HCC (ANHC, AFP < 20 ng/mL) patients, AFP-positive HCC (APHC, AFP ≥ 20 ng/mL) patients were more likely to feature a larger tumor diameter, more vessel invasion, more advanced BCLC, and TNM stage6,7.